Gene · 5934
Papers3,186
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,186
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Loss of CDK4/6 activity in S/G2 phase leads to cell cycle reversal. | Nature | 2023 | 37407814 | PubTator, text mining | PubMed |
| RBL2 Regulates Cardiac Sensitivity to Anthracycline Chemotherapy. | JACC CardioOncol | 2023 | 37397090 | PubTator, text mining | PubMed |
| New Insight Into Cardioprotection From Anthracyclines: Still Converging on the Mitochondria. | JACC CardioOncol | 2023 | 37397073 | PubTator, text mining | PubMed |
| Biallelic FBXW7 knockout induces AKAP8-mediated DNA damage in neighbouring wildtype cells. | Cell Death Discov | 2023 | 37386001 | PubTator, text mining | PubMed |
| Polymorphisms of Fat Mass and Obesity-Associated Gene in the Pathogenesis of Child and Adolescent Metabolic Syndrome. | Nutrients | 2023 | 37375547 | PubTator, text mining | PubMed |
| Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer. | Cancers (Basel) | 2023 | 37370686 | PubTator, text mining | PubMed |
| Plausibility of natural immunomodulators in the treatment of COVID-19-A comprehensive analysis and future recommendations. | Heliyon | 2023 | 37366526 | PubTator, text mining | PubMed |
| Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex. | Cancer Res | 2023 | 37352376 | PubTator, text mining | PubMed |
| The clinicopathological and prognostic significances of EZH2 expression in urological cancers: A meta‑analysis and bioinformatics analysis. | Oncol Lett | 2023 | 37346412 | PubTator, text mining | PubMed |
| Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor. | Oncogene | 2023 | 37330596 | PubTator, text mining | PubMed |
| MDM2- an indispensable player in tumorigenesis. | Mol Biol Rep | 2023 | 37314603 | PubTator, text mining | PubMed |
| Understanding the role of social media usage and health self-efficacy in the processing of COVID-19 rumors: A SOR perspective. | Data Inf Manag | 2023 | 37304677 | PubTator, text mining | PubMed |
| Pan-cancer analysis of Homeobox B9 as a predictor for prognosis and immunotherapy in human tumors. | Aging (Albany NY) | 2023 | 37301547 | PubTator, text mining | PubMed |
| Low CDK Activity and Enhanced Degradation by APC/CCDH1 Abolishes CtIP Activity and Alt-EJ in Quiescent Cells. | Cells | 2023 | 37296650 | PubTator, text mining | PubMed |
| Human Immunodeficiency Virus Related Non-Hodgkin's Lymphoma. | Blood Lymphat Cancer | 2023 | 37275434 | PubTator, text mining | PubMed |
| MicroRNA-372 acts as a double-edged sword in human cancers. | Heliyon | 2023 | 37251909 | PubTator, text mining | PubMed |
| A senescence-associated signature refines the classification of different modification patterns and characterization of tumor immune microenvironment infiltration in triple-negative breast cancer. | Front Pharmacol | 2023 | 37251343 | PubTator, text mining | PubMed |
| Large-scale microRNA functional high-throughput screening identifies miR-515-3p and miR-519e-3p as inducers of human cardiomyocyte proliferation. | iScience | 2023 | 37250320 | PubTator, text mining | PubMed |
| Emerging Role and Mechanism of the FTO Gene in Cardiovascular Diseases. | Biomolecules | 2023 | 37238719 | PubTator, text mining | PubMed |
| Modeling breast cancer proliferation, drug synergies, and alternating therapies. | iScience | 2023 | 37234088 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5934/papers?page=8